• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

IDO upregulation outcome with chemotherapeutics in blood cancer

Badpack

Senior Member
Messages
382
Here an interesting study, that maybe support the ido hypothesis- i found that interesting because it is the same treatment- protocol like in Norway by the first ME/CFS Patients 2003 !
Later the switched to monotherapies with likely less good results!
Maybe we need different immune-agents at the same time to have success?

Maybe you can look over it @HTester - thanks


159C1B3D-4957-4266-B759-AB8E2A5C5A21.png
159C1B3D-4957-4266-B759-AB8E2A5C5A21.png
 

sb4

Senior Member
Messages
1,660
Location
United Kingdom
So the better IDO is working the more successful chemo is? So that would suggest if CFS does have low IDO activity then we wouldn't respond to chemo as well?
 

Badpack

Senior Member
Messages
382
@sb4 - at first i understand it like you , but they talk about an increase- that is only possibible when you measure before and after- so i think after treatment it was higher than before- and that predict the outcome. What is your opinion ?